News >

Targeting Gastric Cancer: Recent Advances Generate Fresh Hopes After Many Frustrations

Jane de Lartigue, PhD
Published: Wednesday, Mar 11, 2015

Cancer cell In the hopes of recreating the successes achieved in other solid malignancies, researchers have evaluated many types of targeted therapy for the treatment of advanced gastric cancer. Regulatory approval of trastuzumab (Herceptin) in 2010 was a step forward, but only a minority of patients is eligible for the human epidermal growth factor receptor 2 (HER2)-targeting antibody therapy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Medical Crossfire: The Advent of CAR T-Cell Therapy for Lymphoid Malignancies and BeyondSep 28, 20191.5
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication